Both TNFα-stimulated gene 6 (TNFAIP6) [24] and methyltransferase-like protein 5 (METTL5) enhance PKM2 expression and activation through the c-Myc axis, promoting glycolytic reprogramming and contributing HCC progression [25]. The gene discussed is METTL5; the disease is hepatocellular carcinoma.